Apelin: A New Heart-Lung Peptide Biomarker Complementing BNP
Apelin, a novel peptide, was identified as a plasma marker of cardiopulmonary disease, with levels distinguishing cardiac from respiratory causes of symptoms and complementing natriuretic peptide testing.
Quick Facts
What This Study Found
Plasma apelin levels differentiated between cardiac and pulmonary disease causes and provided complementary prognostic information alongside natriuretic peptides — a new peptide biomarker for cardiopulmonary disease characterization.
Key Numbers
How They Did This
cross-sectional study on neuropeptides, natriuretic-peptides.
Why This Research Matters
Relevant for neuropeptides, natriuretic-peptides, cardiovascular, respiratory.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Plasma apelin levels differentiated between cardiac and pulmonary disease causes and provided complementary prognostic information alongside natriuret
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2006.
- Original Title:
- Apelin: a new plasma marker of cardiopulmonary disease.
- Published In:
- Regulatory peptides, 133(1-3), 134-8 (2006)
- Authors:
- Goetze, Jens Peter, Rehfeld, Jens F(4), Carlsen, Jørn, Videbaek, Regitze, Andersen, Claus B, Boesgaard, Soeren, Friis-Hansen, Lennart
- Database ID:
- RPEP-01141
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What was studied?
Apelin: A New Heart-Lung Peptide Biomarker Complementing BNP
What was found?
Apelin, a novel peptide, was identified as a plasma marker of cardiopulmonary disease, with levels distinguishing cardiac from respiratory causes of symptoms and complementing natriuretic peptide testing.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01141APA
Goetze, Jens Peter; Rehfeld, Jens F; Carlsen, Jørn; Videbaek, Regitze; Andersen, Claus B; Boesgaard, Soeren; Friis-Hansen, Lennart. (2006). Apelin: a new plasma marker of cardiopulmonary disease.. Regulatory peptides, 133(1-3), 134-8.
MLA
Goetze, Jens Peter, et al. "Apelin: a new plasma marker of cardiopulmonary disease.." Regulatory peptides, 2006.
RethinkPeptides
RethinkPeptides Research Database. "Apelin: a new plasma marker of cardiopulmonary disease." RPEP-01141. Retrieved from https://rethinkpeptides.com/research/goetze-2006-apelin-a-new-plasma
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.